# Severe alcohol use and COVID-19: implications for physical and mental health

**Authors:** Javier Calleja-Conde, Víctor Echeverry-Alzate, Sara Sánchez-Diez, Elena Giné, Kora-Mareen Bühler

PMC · DOI: 10.3389/fpsyt.2025.1640207 · 2025-11-05

## TL;DR

This paper explores how severe alcohol use interacts with COVID-19, worsening both physical and mental health outcomes through shared biological mechanisms.

## Contribution

The paper novelly integrates biological pathways linking alcohol use and COVID-19, emphasizing their combined impact on immune and mental health.

## Key findings

- Chronic alcohol use and COVID-19 both impair immune responses and disrupt cytokine signaling.
- Alcohol-related immune dysfunction may increase the risk of persistent neuropsychiatric symptoms in Long COVID.
- Alcohol use disorder should be integrated into clinical management and mental health care for COVID-19 patients.

## Abstract

The COVID-19 pandemic has revealed and intensified the vulnerability of individuals with pre-existing medical and behavioral conditions, notably those related to substance use. Among these, chronic alcohol consumption represents a clinically significant, yet often under-addressed, vulnerability factor that may exacerbate both the acute severity and long-term consequences of SARS-CoV-2 infection. This narrative review examines the biological and clinical intersections between alcohol use and COVID-19, focusing on shared mechanisms of immune dysfunction, neuroinflammation, and disruption of the gut–brain axis. We synthesize current findings showing that both conditions compromise innate and adaptive immune responses, alter cytokine signaling, and weaken mucosal and blood–brain barriers. These changes contribute to cognitive and emotional dysregulation and may increase the risk of persistent neuropsychiatric symptoms, including those observed in Long COVID. In addition, we discuss how chronic alcohol use may alter host susceptibility to infection and affect the immune response to vaccination, with implications for treatment outcomes and recovery. Our findings highlight the need to integrate alcohol use disorder into COVID-19 risk assessments, clinical management, and long-term mental health care planning. A multidisciplinary approach is essential to address the overlapping biological pathways that link alcohol-related vulnerability to COVID-19 outcomes.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** Long COVID (MESH:D000094024), COVID-19 (MESH:D000086382), immune dysfunction (MESH:D007154), neuroinflammation (MESH:D000090862), alcohol use disorder (MESH:D000437), neuropsychiatric symptoms (MESH:D001523), infection (MESH:D007239)
- **Chemicals:** alcohol (MESH:D000438)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12626925/full.md

---
Source: https://tomesphere.com/paper/PMC12626925